A senior executive at Baxter International recently pointed out that the company’s first-quarter business still faces ongoing challenges caused by the return of Novum infusion devices.

Despite the measures taken, fluctuations in market acceptance of this product continue to cast a shadow over performance. Meanwhile, uncertainty in customer purchasing behavior persists. Medical institutions are showing a more cautious attitude in their equipment procurement decisions, a trend that may directly impact Baxter International's short-term revenue. Industry observers believe that the medical device sector is undergoing a structural adjustment in supply and demand relationships.